Goldman Sachs Resumes Pfizer (PFE) at Neutral
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $25.26 -3.84%
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
13 Buy, 20 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Goldman Sachs resumed coverage on Pfizer (NYSE: PFE) with a Neutral rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $32.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer Declares Second-Quarter 2024 Dividend
- Goldman Sachs Resumes JD.com, Inc (JD) at Buy
- Bernstein SocGen Group Starts General Motors (GM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
